GlaxoSmithKline - Orange Cards™ Key Facts

(October 4, 2001) GlaxoSmithKline introduced a program to offer savings on its outpatient prescription medicines directly to eligible low-income seniors and the disabled.

Eligible are:
senior citizens age 65 and older and the disabled enrolled in Medicare · with annual incomes below $26,000 single / $35,000 for a couple (300% of poverty level - $25,770 single and $34,830 couple)
who do not have public or private insurance coverage for prescription medicines.

Application process:
The application is easy.
Applicants will be asked for basic information, such as their name, mailing address, date of birth, etc., as well as annual income, and whether they already have public or private insurance coverage for prescription medicines.
Applicants will be asked to submit their Medicare number.
Mail in the application.

Application and program dates:
Applications will be available November 1 through healthcare providers or by calling 1-888-Orange6. [NOTE: we will begin taking requests for applications via this toll free number immediately, with applications mailed by November 1.]
Those eligible will receive their card within 4 weeks after their application has been received, but not before January 1, 2002.
Participants can begin using their Orange Card on January 1, 2002.

How the savings works:
The Orange Card is designed so participants will realize average savings of 30% off the usual price they pay for outpatient GSK medicines. In some cases, savings may be 40% or greater.*

To use the card:
The Orange Card participant presents the Orange Card with their prescription for a GSK product to a participating pharmacy · The patient will realize the savings at the point of sale.

Medicines covered:
All GlaxoSmithKline outpatient products are included in the program. This list includes Advairâ (fluticasone propionate and salmeterol inhalation powder), Avandiaâ (rosiglitazone maleate), Coregâ (carvedilol), Flonaseâ (fluticasone propionate), Floventâ (fluticasone propionate), Imitrexâ(sumatriptan), Lamictalâ (lamotrigine), Lanoxinâ (digoxin), Paxilâ (paroxetine hydrochloride), Requipâ (ropinirole hydrochloride), Sereventâ (salmeterol xinafoate), Wellbutrin SRâ (bupropion hydrochloride), Zofranâ tablets (ondansetron hydrochloride) and Zybanâ (bupropion hydrochloride SR).
GSK's OTC products and in-patient prescription medicines are not eligible for Orange Card savings. This would include vaccines, hospital medicines and physician administered medicines (e.g. Navelbine, Zofran IV) which are all paid for by other programs.